Unibest
← Back to patent-cliff list

CAS 1075240-41-3

(4S,4aS,5aR,12aS)-9-((2-chloro-N-neopentylacetamido)methyl)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-N-(hydroxymethyl)-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide

Codes: OMAD-013

Application context (from source-drug indications)

Skin and skin structure infectionOmadacycline tosylateCommunity-acquired bacterial pneumoniaOmadacycline tosylateBacterial infectionOmadacycline tosylateBacterial pneumoniaOmadacycline tosylateBacterial skin diseaseOmadacycline tosylate

Source drugs (routes using this intermediate)

DrugTierExpiry
Omadacycline tosylateTier C — Watch / trade2030

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Omadacycline tosylateOptimised routesteps: 5total yield: /
2,2-dimethylpropan-1-amine→(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride→1,3,5-trineopentyl-1,3,5-triazinane→2-chloroacetic anhydride→(2-chloro-N-neopentylacetamido)methyl 2-chloroacetate→(4S,4aS,5aR,12aS)-9-((2-chloro-N-neopentylacetamido)methyl)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-N-(hydroxymethyl)-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide→(4aS,5aR,12aS)-9-((2-chloro-N-neopentylacetamido)methyl)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.